Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Sarcoma
What dose-fractionation and clinical target volume do you use when treating tenosynovial giant cell tumor (TGCT), historically known as pigmented villonodular synovitis (PVNS), of the knee?
Answer from: Radiation Oncologist at Community Practice
4500 cGy at 180cGy/fx.
Sign In
or
Register
to read more
14297
Related Questions
How would you manage an epidural spinal metastasis causing cord compression from rhabdomyosarcoma?
How do you consider SBRT relative to other emerging therapies for pediatric sarcomas, such as proton therapy or immunotherapy, in terms of efficacy and safety?
How would you treat an unresectable epithelioid angiosarcoma invading the cavernous sinus, wrapping around the carotid artery?
What dose fractionation would you use to palliate a metastatic peripheral nerve sheath tumor of the lower extremity with bulky inguinal adenopathy?
Would you recommend adjuvant radiation for a large dedifferentiated anterior abdominal wall liposarcoma?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
Would you include draining lymphatics as part of an adjuvant radiotherapy course following gross total resection of sinonasal sarcoma?
How would you treat a primary angiosarcoma arising in the skull, excised with initial excisional biopsy?
In a patient with an R1 resection of a chordoma who has declined proton therapy, what alternative radiation modality would you recommend?
What are your top takeaways in GU Cancers from ASCO 2025?